ESC 365 - The CaMKII inhibitor RA123456 attenuates heart failure and prevents ventricular and atrial arrhythmias in vivo

ESC Premium Access

The CaMKII inhibitor RA123456 attenuates heart failure and prevents ventricular and atrial arrhythmias in vivo

Session: Novel pharmacological therapy in chronic heart failure

Topic: Pharmacologic therapy

Speaker: Doctor J. Mustroph (Regensburg, DE)

Event: ESC Congress 2016

Congress Presentation

About the speaker

Doctor Julian Mustroph

University Hospital Regensburg, Regensburg (Germany)

0 follower

6 more presentations in this session

Contribution of central donepezil to prevention of cardiac dysfunction and improvement of long-term survival in chronic heart failure rats after myocardial infarction

Speaker: Doctor M. Li (Osaka, JP)

Stimulation of the soluble guanylate cyclase attenuates pressure-overload induced cardiac hypertrophy in mice

Speaker: Doctor J. Ruedebusch (Greifswald, DE)

Magnesium orotate improves symptoms, exercise capacity and quality of life in patients with valve prosthesis: results from a randomized, open-label, case-control 2-year study

Speaker: Professor I. Gaisin (Izhevsk, RU)

Effect of ipragliflozin, a sodium-glucose co-transporter 2 inhibitor, on diuresis and neurohormonal activation in type 2 diabetes mellitus and heart failure

Speaker: Doctor T. Takeuchi (Tsu, JP)

Get the right balance: a novel vasopressin receptor antagonist equally blocks human V1a and V2 receptors and inhibits the release of plasminogen activator inhibitor-1 from cardiomyocytes

Speaker: Doctor P. Kolkhof (Wuppertal, DE)

Access the full session

Novel pharmacological therapy in chronic heart failure

Speakers: Doctor J. Mustroph, Doctor M. Li, Doctor J. Ruedebusch, Professor I. Gaisin, Doctor T. Takeuchi...

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by